Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY. [PDF]
Kidney360Allegretti AS.
europepmc +1 more source
Human orthotopic liver transplantation: surgical aspects in 393 consecutive grafts. [PDF]
, 1988 Gordon, RD +3 more
core
Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats. [PDF]
World J NephrolDuailibe JBB +4 more
europepmc +1 more source
Comparison of hepatorenal syndrome incidence and outcomes using previous and current diagnostic criteria in cirrhotic patients. [PDF]
Hepatol ForumAkbas MM +3 more
europepmc +1 more source
Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis. [PDF]
Front PharmacolWan YM +5 more
europepmc +1 more source
Comparative Mortality Rates of Vasoconstrictor Agents in the Management of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis. [PDF]
CureusOlayinka OT +6 more
europepmc +1 more source
Development and validation of a machine learning-based prediction model for hepatorenal syndrome in liver cirrhosis patients using MIMIC-IV and eICU databases. [PDF]
Sci RepYao F, Luo J, Zhou Q, Wang L, He Z.
europepmc +1 more source
Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome. [PDF]
Cochrane Database Syst RevGonzalez-Garay AG +4 more
europepmc +1 more source
Retraction Note: Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals. [PDF]
Biol Trace Elem ResKamel EO +5 more
europepmc +1 more source